MedTrace Logo

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

NCT00393276 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2021-11-01

No results posted yet for this study

Summary

Infection with either HIV or hepatitis C virus (HCV) affects immune system responses. The purpose of this study is to investigate the immune responses to two different vaccine formulations in HIV-infected, HCV-infected, and HCV/HIV- coinfected individuals.

Conditions

  • HIV Infections
  • Hepatitis C

Interventions

BIOLOGICAL

Twinrix

Combined hepatitis A and hepatitis B immunization

BIOLOGICAL

Decavac

Diphtheria and tetanus toxoid vaccine

Sponsors & Collaborators

  • Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

    collaborator NETWORK

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Donald D. Anthony, MD, PhD · Case Western Reserve University

  • Benigno Rodriguez, MD · Division of Infectious Diseases, University Hospital of Cleveland

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00393276 on ClinicalTrials.gov